Research Developments in COPD

To participate in this activity, please:

The latest research related to the treatment of patients with COPD is often first made public at the annual CHEST meeting. In this CME activity, Barbara Yawn, MD, provides an introduction related to the role of triple inhaled therapy in selected patients with COPD to treat symptoms and prevent exacerbations.  She discusses 3 posters presented at the 2021 CHEST meeting related to triple therapy. Dr. Yawn first summarizes the methods and results of each of these posters, then provides her own thoughts as to the importance of the research findings and implications for clinical practice in the treatment of patients with COPD.

Course Credit:

0.75 AMA PRA Category 1 CreditsTM

Dates:

Opens: 2021-11-12
Closes: 2022-11-12

Target Audience:

This activity is intended for pulmonologists, allergists, critical care specialists, primary care physicians, and other clinicians involved in the management of patients with COPD.

This activity is supported by an educational grant from AstraZeneca.

Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Content Planners

Eugene Cullen, MD (Peer Reviewer)
No significant relationships to disclose.

Tim Drake, PharmD (Medical Writer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Presenting Faculty

  • Barbara P. Yawn, MD

    Adjunct Professor
    University of Minnesota
    Department of Family and Community Health
    Minneapolis, Minnesota

Learning Objectives

  • Describe how new data and recommendations can impact clinical practices to improve care
  • Incorporate evidence-based research into clinical practice

Faculty Disclosures

Barbara P. Yawn, MD

Advisory Board: AstraZeneca, Boehringer Ingelheim, GSK, Novartis, TEVA

Consultant: TEVA

Research Support: GSK